0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-35.05%
Negative revenue growth while 9698.HK stands at 9.26%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-57.37%
Negative gross profit growth while 9698.HK is at 10.84%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-12840.57%
Negative operating income growth while 9698.HK is at 21.65%. Joel Greenblatt would press for urgent turnaround measures.
-10932.16%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11650.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11650.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.05%
Share reduction while 9698.HK is at 0.27%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-145.25%
Negative OCF growth while 9698.HK is at 1601.32%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-147.96%
Negative FCF growth while 9698.HK is at 34.53%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-88.24%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-90.44%
Negative 5Y CAGR while 9698.HK stands at 584.94%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-86.96%
Negative 3Y CAGR while 9698.HK stands at 100.17%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-124.41%
Negative 10Y OCF/share CAGR while 9698.HK stands at 200.43%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
81.82%
Below 50% of 9698.HK's 5265.14%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-118.11%
Negative 3Y OCF/share CAGR while 9698.HK stands at 1458.46%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-162.72%
Negative 10Y net income/share CAGR while 9698.HK is at 79.40%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-217.56%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-335.11%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
20.43%
Equity/share CAGR of 20.43% while 9698.HK is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-6.22%
Negative 5Y equity/share growth while 9698.HK is at 1069.56%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-2.73%
Negative 3Y equity/share growth while 9698.HK is at 218.67%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 9698.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 9698.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-43.19%
Firm’s AR is declining while 9698.HK shows 15.77%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-48.62%
Inventory is declining while 9698.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-15.40%
Negative asset growth while 9698.HK invests at 7.11%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.86%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-23.89%
We’re deleveraging while 9698.HK stands at 13.26%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-12.52%
We cut SG&A while 9698.HK invests at 6.58%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.